Free Trial

Q4 Earnings Estimate for AMPX Issued By Northland Securities

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Northland Securities raised its Q4 2026 EPS estimate for Amprius to $0.01 (from -$0.01) and now forecasts FY2027 EPS of $0.18, signaling an upgraded earnings outlook.
  • Amprius beat Q4 expectations with reported EPS of -$0.01 versus a -$0.04 consensus and revenue of $25.23M (vs. $22.91M), and the company noted record revenue growth and its first positive adjusted quarterly EBITDA.
  • Analyst sentiment has turned bullish with several firms lifting price targets into the low-$20s (consensus target ~$19.75, "Moderate Buy"), but insiders sold ~2.39M shares recently and the company remains GAAP-unprofitable, leaving share volatility as a key risk.
  • Five stocks we like better than Amprius Technologies.

Amprius Technologies, Inc. (NYSE:AMPX - Free Report) - Investment analysts at Northland Securities upped their Q4 2026 EPS estimates for Amprius Technologies in a research report issued on Monday, March 9th. Northland Securities analyst E. Jackson now forecasts that the company will post earnings of $0.01 per share for the quarter, up from their prior estimate of ($0.01). The consensus estimate for Amprius Technologies' current full-year earnings is ($0.45) per share. Northland Securities also issued estimates for Amprius Technologies' Q1 2027 earnings at $0.04 EPS, Q2 2027 earnings at $0.04 EPS, Q3 2027 earnings at $0.05 EPS, Q4 2027 earnings at $0.05 EPS and FY2027 earnings at $0.18 EPS.

Amprius Technologies (NYSE:AMPX - Get Free Report) last announced its earnings results on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. The business had revenue of $25.23 million during the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS.

A number of other analysts have also recently weighed in on the company. B. Riley Financial increased their price objective on Amprius Technologies from $16.00 to $22.00 and gave the stock a "buy" rating in a research report on Monday. Roth Mkm reissued a "buy" rating and issued a $20.00 target price (up from $16.00) on shares of Amprius Technologies in a report on Friday. Weiss Ratings restated a "sell (e+)" rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. William Blair reaffirmed an "outperform" rating on shares of Amprius Technologies in a report on Friday. Finally, Cantor Fitzgerald boosted their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a research note on Friday. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $19.75.

Read Our Latest Report on AMPX

Amprius Technologies Stock Up 8.5%

Shares of AMPX stock opened at $17.72 on Tuesday. The stock has a market capitalization of $2.31 billion, a PE ratio of -52.10 and a beta of 3.04. Amprius Technologies has a 52-week low of $1.70 and a 52-week high of $17.74. The stock's 50-day moving average price is $11.07 and its 200 day moving average price is $10.82.

Insider Activity at Amprius Technologies

In related news, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the completion of the transaction, the chief technology officer directly owned 748,696 shares in the company, valued at $9,014,299.84. The trade was a 39.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kang Sun sold 950,548 shares of the firm's stock in a transaction on Friday, January 16th. The stock was sold at an average price of $11.07, for a total value of $10,522,566.36. Following the transaction, the director directly owned 1,403,651 shares of the company's stock, valued at $15,538,416.57. The trade was a 40.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,392,269 shares of company stock valued at $26,384,359 over the last 90 days. Insiders own 12.80% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in AMPX. Vanguard Group Inc. boosted its holdings in shares of Amprius Technologies by 9.5% during the fourth quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company's stock worth $56,245,000 after purchasing an additional 616,037 shares during the last quarter. Geode Capital Management LLC lifted its position in Amprius Technologies by 10.5% during the fourth quarter. Geode Capital Management LLC now owns 2,678,417 shares of the company's stock worth $21,137,000 after buying an additional 253,529 shares during the period. State Street Corp lifted its position in Amprius Technologies by 16.6% during the fourth quarter. State Street Corp now owns 2,553,710 shares of the company's stock worth $20,149,000 after buying an additional 363,928 shares during the period. Invesco Ltd. boosted its stake in Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock worth $25,031,000 after buying an additional 1,263,846 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in Amprius Technologies by 23.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,194,841 shares of the company's stock valued at $17,317,000 after buying an additional 410,724 shares during the period. Hedge funds and other institutional investors own 5.04% of the company's stock.

Key Stories Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Multiple analysts raised ratings and price targets (buy ratings and targets in the low-$20s), signaling more institutional conviction and a higher consensus valuation. Read More.
  • Positive Sentiment: MarketBeat highlights record trading volume tied to the Q4 release — volume-backed breakouts increase the odds the rally continues because they show real market conviction. Read More.
  • Positive Sentiment: Q4 results showed record revenue growth and the company reported its first positive adjusted quarterly EBITDA; management cited expanding adoption of its 2nd‑gen silicon‑anode batteries and new commercial/defense wins. Read More.
  • Positive Sentiment: IBD upgraded AMPX, adding a reputable media/ratings endorsement that can attract momentum investors and retail flows. Read More.
  • Neutral Sentiment: Analyst fair‑value estimates have moved higher (consensus and some firms into the ~$20–22 range), but coverage remains relatively light — helpful for upside if coverage expands, yet still leaves forecasts dispersed. Read More.
  • Negative Sentiment: Despite progress, Amprius remains unprofitable on a GAAP basis and guidance/consensus EPS still negative for the year; valuation and momentum make the stock volatile (high beta), so downside risk exists if growth or NDAA/compliance milestones slip. Read More.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Further Reading

Earnings History and Estimates for Amprius Technologies (NYSE:AMPX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines